Cargando…

Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease

Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1...

Descripción completa

Detalles Bibliográficos
Autores principales: Weill, Yishay, Zimran, Ari, Zadok, David, Wasser, Lauren M., Revel-Vilk, Shoshana, Hanhart, Joel, Dinur, Tama, Arkadir, David, Becker-Cohen, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582605/
https://www.ncbi.nlm.nih.gov/pubmed/32987733
http://dx.doi.org/10.3390/ijms21197027
_version_ 1783599229867917312
author Weill, Yishay
Zimran, Ari
Zadok, David
Wasser, Lauren M.
Revel-Vilk, Shoshana
Hanhart, Joel
Dinur, Tama
Arkadir, David
Becker-Cohen, Michal
author_facet Weill, Yishay
Zimran, Ari
Zadok, David
Wasser, Lauren M.
Revel-Vilk, Shoshana
Hanhart, Joel
Dinur, Tama
Arkadir, David
Becker-Cohen, Michal
author_sort Weill, Yishay
collection PubMed
description Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1 individuals and 30 healthy volunteers between the ages 40–75 years were prospectively enrolled. Macular and optic nerve optical coherence tomography (OCT) scans of both eyes of each patient were performed and thickness maps were compared between groups. Patients with a known neurodegenerative disease, glaucoma, high myopia and previous intraocular surgeries were excluded. It was shown that patients with GD1 presented with higher incidence of abnormal pRNFL OCT scan and showed significantly thinner areas of pRNFL and macular ganglion cell complex (GCC) when compared to a healthy control population. Changes in retinal thickness were not associated with GD1 genotype, treatment status, disease monitoring biomarker (lyso-Gb1) and severity score index (Zimran SSI). Further investigations are needed to determine whether these findings possess functional visual implications and if retinal thinning may serve as biomarker for the development of future neurodegenerative disease in this population.
format Online
Article
Text
id pubmed-7582605
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75826052020-10-28 Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease Weill, Yishay Zimran, Ari Zadok, David Wasser, Lauren M. Revel-Vilk, Shoshana Hanhart, Joel Dinur, Tama Arkadir, David Becker-Cohen, Michal Int J Mol Sci Communication Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1 individuals and 30 healthy volunteers between the ages 40–75 years were prospectively enrolled. Macular and optic nerve optical coherence tomography (OCT) scans of both eyes of each patient were performed and thickness maps were compared between groups. Patients with a known neurodegenerative disease, glaucoma, high myopia and previous intraocular surgeries were excluded. It was shown that patients with GD1 presented with higher incidence of abnormal pRNFL OCT scan and showed significantly thinner areas of pRNFL and macular ganglion cell complex (GCC) when compared to a healthy control population. Changes in retinal thickness were not associated with GD1 genotype, treatment status, disease monitoring biomarker (lyso-Gb1) and severity score index (Zimran SSI). Further investigations are needed to determine whether these findings possess functional visual implications and if retinal thinning may serve as biomarker for the development of future neurodegenerative disease in this population. MDPI 2020-09-24 /pmc/articles/PMC7582605/ /pubmed/32987733 http://dx.doi.org/10.3390/ijms21197027 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Weill, Yishay
Zimran, Ari
Zadok, David
Wasser, Lauren M.
Revel-Vilk, Shoshana
Hanhart, Joel
Dinur, Tama
Arkadir, David
Becker-Cohen, Michal
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title_full Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title_fullStr Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title_full_unstemmed Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title_short Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
title_sort macular ganglion cell complex and peripapillary retinal nerve fiber layer thinning in patients with type-1 gaucher disease
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582605/
https://www.ncbi.nlm.nih.gov/pubmed/32987733
http://dx.doi.org/10.3390/ijms21197027
work_keys_str_mv AT weillyishay macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT zimranari macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT zadokdavid macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT wasserlaurenm macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT revelvilkshoshana macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT hanhartjoel macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT dinurtama macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT arkadirdavid macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease
AT beckercohenmichal macularganglioncellcomplexandperipapillaryretinalnervefiberlayerthinninginpatientswithtype1gaucherdisease